Fowl Cholera in Poultry: Etiology, Pathogenesis, and Management

Introduction

Fowl cholera, also known as avian pasteurellosis, is a highly contagious bacterial disease affecting domestic poultry, waterfowl, and numerous wild bird species. The disease is caused by the Gram-negative bacterium Pasteurella multocida and manifests primarily as an acute septicemia with high morbidity and mortality, though chronic and subacute forms are also recognized. Fowl cholera represents a significant economic burden to the poultry industry worldwide due to mortality, reduced egg production, and costs associated with treatment and prevention. This article provides a detailed examination of the etiological agent, pathogenesis, clinical presentation, diagnostic approaches, therapeutic interventions, and management strategies for fowl cholera in poultry.

Etiology

The Causative Agent: Pasteurella multocida

Pasteurella multocida is a small, non-motile, Gram-negative coccobacillus belonging to the family Pasteurellaceae. The bacterium is facultatively anaerobic and exhibits bipolar staining when treated with methylene blue or Giemsa stain, a characteristic that aids in preliminary microscopic identification. P. multocida is classified into five capsular serogroups (A, B, D, E, F) based on capsular polysaccharide antigens and 16 somatic lipopolysaccharide serotypes (1 through 16) determined by heat-stable antigen typing. In avian species, capsular serogroup A and somatic serotypes 1, 3, and 4 are most frequently associated with fowl cholera outbreaks.

The bacterium possesses several virulence factors that facilitate colonization, immune evasion, and tissue damage. The polysaccharide capsule is a critical antiphagocytic component that inhibits complement-mediated opsonization and phagocytosis by avian macrophages. Lipopolysaccharide (LPS) molecules in the outer membrane act as endotoxins, triggering a potent inflammatory response that contributes to the pathophysiology of septic shock. Fimbriae and other adhesins mediate attachment to respiratory epithelial cells, while outer membrane proteins (OMPs) and iron acquisition systems enable survival within the host environment.

Strain Variation and Host Specificity

Considerable genetic and phenotypic diversity exists among P. multocida isolates. Strains vary in virulence, host range, and tissue tropism. Some strains are highly virulent for chickens but less pathogenic for turkeys, while others exhibit broad host specificity. Molecular typing methods, including restriction endonuclease analysis (REA), pulsed-field gel electrophoresis (PFGE), and multilocus sequence typing (MLST), have been employed to characterize outbreak strains and trace transmission pathways.

Epidemiology

Host Range and Susceptibility

Fowl cholera affects a wide range of avian species. Among domestic poultry, turkeys are generally more susceptible than chickens, with higher mortality rates observed in turkey flocks. Ducks and geese are also highly susceptible and may serve as reservoirs for P. multocida strains pathogenic to chickens. Game birds such as pheasants, quail, and partridges are similarly vulnerable. Wild waterfowl, including migratory ducks and geese, play a significant role in the epidemiology of fowl cholera by introducing the pathogen into domestic poultry operations.

Transmission and Risk Factors

Transmission of P. multocida occurs primarily through direct contact between infected and susceptible birds. The bacterium is shed in oral, nasal, and conjunctival secretions, as well as in feces. Contaminated feed, water, equipment, and fomites serve as indirect transmission vehicles. Rodents, free-flying birds, and insects may act as mechanical vectors. The respiratory route is considered the primary portal of entry, with the bacterium colonizing the upper respiratory tract before disseminating systemically.

Risk factors for fowl cholera outbreaks include high stocking density, poor ventilation, nutritional stress, concurrent infections (e.g., infectious coryza, mycoplasmosis), and inadequate biosecurity measures. Stressors such as transport, extreme temperatures, and vaccination can precipitate clinical disease in latently infected carriers.

Pathogenesis

Colonization and Invasion

Following inhalation or ingestion, P. multocida adheres to the mucosal epithelium of the upper respiratory tract and oropharynx. The bacterium resists mucociliary clearance through capsular polysaccharide and fimbrial adhesins. Once established, P. multocida invades the submucosa and gains access to the bloodstream, leading to bacteremia. The precise mechanisms of systemic dissemination involve evasion of phagocytic killing and intracellular survival within macrophages.

Septicemia and Endotoxic Shock

The acute phase of fowl cholera is characterized by rapid bacterial proliferation in the blood and reticuloendothelial organs, including the liver, spleen, and bone marrow. The release of LPS endotoxin triggers a cascade of pro-inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 (IL-1), and interleukin-6 (IL-6). This cytokine storm induces vasodilation, increased vascular permeability, disseminated intravascular coagulation (DIC), and multi-organ failure. The resulting endotoxic shock is the primary cause of peracute death in affected birds.

Chronic Lesion Formation

In birds that survive the acute septicemic phase, or in those infected with less virulent strains, P. multocida may localize to specific tissues, leading to chronic localized infections. Common sites include the wattles, sinuses, joints, tendon sheaths, and sternal bursae. Fibrinous and purulent inflammation at these sites results in characteristic lesions such as swollen wattles, synovitis, and abscess formation.

Clinical Signs

Peracute and Acute Forms

The peracute form of fowl cholera is seen most frequently in highly susceptible flocks, particularly turkeys. Birds are found dead without premonitory signs. In the acute form, clinical signs develop rapidly over 12 to 24 hours and include fever (elevated body temperature), depression, anorexia, ruffled feathers, cyanosis of the comb and wattles, and mucoid to bloody diarrhea. Respiratory signs such as dyspnea, rales, and nasal discharge are common. Mortality rates in acute outbreaks can reach 50% or higher in untreated flocks.

Chronic Form

Chronic fowl cholera typically follows an acute outbreak or occurs in flocks infected with low-virulence strains. Clinical manifestations include localized swelling of the wattles (wattle edema), sinuses (sinusitis), and joints (arthritis). Torticollis (wry neck) may result from infection of the inner ear or meninges. Affected birds exhibit lameness, reduced feed intake, and decreased egg production. Chronic cases may persist for weeks, with intermittent shedding of the bacterium.

Pathology

Gross Lesions

Postmortem examination of birds succumbing to acute fowl cholera reveals lesions consistent with septicemia. Petechial and ecchymotic hemorrhages are observed on the epicardium, serosal surfaces of the abdominal viscera, and in the musculature. The liver is enlarged, friable, and often exhibits multiple small, pale necrotic foci (miliary necrosis). The spleen is swollen and congested. Fibrinous pericarditis and airsacculitis may be present. In chronic cases, caseous exudate is found within the wattles, sinuses, and joint cavities.

Histopathology

Microscopic examination of affected tissues reveals acute fibrinous and necrotizing inflammation. Hepatic lesions consist of focal coagulative necrosis surrounded by heterophilic and mononuclear cell infiltrates. Splenic tissue shows lymphoid depletion and fibrin deposition. In the lungs, congestion, edema, and fibrin thrombi are observed. Chronic lesions are characterized by granulomatous inflammation with central caseous necrosis and peripheral fibroplasia.

Diagnosis

Clinical and Epidemiological Assessment

A presumptive diagnosis of fowl cholera is based on the history of acute mortality, characteristic clinical signs, and gross pathological findings. A rapid onset of death in multiple birds, particularly in turkeys, should raise suspicion for fowl cholera.

Laboratory Confirmation

Definitive diagnosis requires isolation and identification of P. multocida from affected tissues. Samples for culture include liver, spleen, bone marrow, heart blood, and exudate from wattles or joints. Swabs are plated onto blood agar or MacConkey agar and incubated at 37°C under microaerophilic conditions. P. multocida appears as small, gray, non-hemolytic colonies on blood agar after 24 to 48 hours. The bacterium is oxidase-positive, catalase-positive, and indole-positive. Bipolar staining with methylene blue is a useful rapid screening method.

Molecular diagnostic techniques, including polymerase chain reaction (PCR) assays targeting the P. multocida-specific KMT1 gene, provide rapid and sensitive detection directly from clinical specimens. PCR-based capsular typing and somatic serotyping are used for epidemiological characterization.

Differential Diagnosis

Fowl cholera must be differentiated from other causes of acute septicemia in poultry, including highly pathogenic avian influenza (HPAI), Newcastle disease, fowl typhoid (Salmonella Gallinarum), pullorum disease (Salmonella Pullorum), and Erysipelothrix rhusiopathiae infection. Chronic forms require differentiation from infectious coryza, mycoplasmosis, and Ornithobacterium rhinotracheale infection.

Treatment

Antimicrobial Therapy

Prompt antimicrobial treatment is essential to reduce mortality in affected flocks. P. multocida is generally susceptible to a range of antibiotics, including tetracyclines, sulfonamides, penicillin, and fluoroquinolones. Water-soluble formulations of oxytetracycline, chlortetracycline, or sulfadimethoxine are commonly administered via drinking water for 3 to 5 days. Ceftiofur and enrofloxacin are also effective but should be used judiciously to minimize the development of antimicrobial resistance.

Antimicrobial susceptibility testing (AST) by disk diffusion or broth microdilution is recommended to guide therapy, particularly in recurrent outbreaks. Resistance to tetracyclines and sulfonamides has been reported in some P. multocida isolates.

Supportive Care

Supportive measures include improving ventilation, reducing stocking density, and ensuring access to clean water and feed. Removal of dead and moribund birds reduces environmental contamination and disease transmission.

Control and Prevention

Biosecurity

Strict biosecurity protocols are the cornerstone of fowl cholera prevention. Measures include controlling access to poultry houses, disinfecting footwear and equipment, preventing contact with wild birds and rodents, and implementing all-in/all-out management practices. Quarantine of newly introduced birds and isolation of sick birds are essential.

Vaccination

Vaccination is a key component of fowl cholera control programs, particularly in endemic areas and high-risk flocks. Both inactivated (bacterin) and live attenuated vaccines are available. Inactivated vaccines are administered parenterally and provide protection against homologous serotypes but may require multiple doses. Live attenuated vaccines, such as the CU (Clemson University) strain, are administered via drinking water or wing-web inoculation and induce both humoral and cell-mediated immunity. However, live vaccines retain some virulence and may cause disease in turkeys or immunocompromised birds.

Autogenous vaccines prepared from local outbreak strains are used when commercial vaccines fail to provide adequate protection due to serotype mismatch.

Management of Carrier Birds

Carrier birds are a major source of P. multocida persistence in flocks. Identification and culling of carriers, combined with antimicrobial therapy, can reduce the prevalence of infection. However, complete eradication of the pathogen from a flock is challenging.

Fowl Cholera in Hindi (मुर्गी हैजा)

In Hindi, fowl cholera is referred to as "मुर्गी हैजा" (Murghi Haiza). The disease is recognized as a significant threat to backyard and commercial poultry operations in the Indian subcontinent. Clinical signs and management principles are consistent with those described globally. Awareness of the disease among smallholder farmers is critical for early detection and control.

Conclusion

Fowl cholera remains a major infectious disease of poultry worldwide, caused by the versatile pathogen Pasteurella multocida. The disease manifests in peracute, acute, and chronic forms, with pathogenesis driven by endotoxin-mediated septic shock and localized inflammation. Accurate diagnosis relies on bacterial culture, molecular detection, and serotyping. Effective management requires a multifaceted approach combining antimicrobial therapy, vaccination, and rigorous biosecurity. Ongoing surveillance for antimicrobial resistance and emerging serotypes is essential for sustaining control efforts.

References

1. Glisson, J.R., Hofacre, C.L., and Christensen, J.P. Fowl Cholera. In: Swayne, D.E., editor. Diseases of Poultry. 14th ed. Wiley-Blackwell; 2020. p. 807-823.
2. Harper, M., Boyce, J.D., and Adler, B. Pasteurella multocida pathogenesis: 125 years after Pasteur. FEMS Microbiology Letters. 2006;265(1):1-10.
3. Wilkie, I.W., Harper, M., Boyce, J.D., and Adler, B. Pasteurella multocida: diseases and pathogenesis. Current Topics in Microbiology and Immunology. 2012;361:1-22.
4. Christensen, J.P., and Bisgaard, M. Fowl cholera. Revue Scientifique et Technique (International Office of Epizootics). 2000;19(2):626-637.
5. Shivaprasad, H.L. Fowl cholera: a review. Avian Diseases. 2000;44(1):1-10.
6. Rhoades, K.R., and Rimler, R.B. Avian pasteurellosis. In: Calnek, B.W., editor. Diseases of Poultry. 10th ed. Iowa State University Press; 1997. p. 181-207.
7. Boyce, J.D., Harper, M., Wilkie, I.W., and Adler, B. Pasteurella multocida. In: Gyles, C.L., Prescott, J.F., Songer, J.G., and Thoen, C.O., editors. Pathogenesis of Bacterial Infections in Animals. 4th ed. Wiley-Blackwell; 2010. p. 325-340.
8. Hunt, M.L., Adler, B., and Townsend, K.M. The molecular biology of Pasteurella multocida. Veterinary Microbiology. 2000;72(1-2):3-25.
9. Dabo, S.M., Taylor, J.D., and Confer, A.W. Pasteurella multocida and bovine respiratory disease. Animal Health Research Reviews. 2007;8(2):129-150.
10. Merck Veterinary Manual. Fowl Cholera. Kenilworth, NJ: Merck & Co., Inc.; 2023.

Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.